Charged pyridinium oximes with thiocarboxamide moiety are equally or less effective reactivators of organophosphate-inhibited cholinesterases compared to analogous carboxamides

References

• Weerasinghe M, Pearson M, Konradsen F, et al. Emerging pesticides responsible for suicide in rural Sri Lanka following the 2008-2014 pesticide bans. BMC Public Health 2020;20:780.
   PubMed Web of Science ®Google Scholar
• Hrabetz H, Thiermann H, Felgenhauer N, et al. Organophosphate poisoning in the developed world - a single centre experience from here to the millennium. Chem Biol Interact 2013;206:561–8.
   PubMed Web of Science ®Google Scholar
• Amend N, Niessen KV, Seeger T, et al. Diagnostics and treatment of nerve agent poisoning-current status and future developments. Ann N Y Acad Sci 2020;1479:13–28.
   PubMed Web of Science ®Google Scholar
• Goldsmith M, Ashani Y. Catalytic bioscavengers as countermeasures against organophosphate nerve agents. Chem Biol Interact 2018;292:50–64.
   PubMed Web of Science ®Google Scholar
• Marrs TC. Organophosphate poisoning. Pharmac. Ther 1993;58:51–66.
   PubMed Web of Science ®Google Scholar
• Munro N. Toxicity of the organophosphate chemical warfare agents GA, GB, and VX: implications for public protection. Environ Health Perspect 1994;102:18–37.
   PubMed Web of Science ®Google Scholar
• Franjesevic AJ, Sillart SB, Beck JM, et al. Resurrection and reactivation of acetylcholinesterase and butyrylcholinesterase. Chemistry 2019;25:5337–71.
   PubMed Web of Science ®Google Scholar
• Hrvat NM, Kovarik Z. Counteracting poisoning with chemical warfare nerve agents. Arh Hig Rada Toksikol 2020;71:266–84.
   PubMed Web of Science ®Google Scholar
• Malinak D, Korabecny J, Soukup O, et al. A review of the synthesis of quaternary acetylcholinesterase reactivators. Curr. Org. Chem 2018;22:1619–48.
   Web of Science ®Google Scholar
• Yerri J, Dias J, Nimmakayala MR, et al. Chemoselective hydrogenation of 6-alkynyl-3-fluoro-2-pyridinaldoximes: access to first-in-class 6-alkyl-3-fluoro-2-pyridinaldoxime scaffolds as new reactivators of sarin-inhibited human acetylcholinesterase with increased blood-brain barrier permeability. Chem. Eur. J 2020;26:15035–44.
   PubMed Web of Science ®Google Scholar
• Zorbaz T, Malinak D, Maraković N, et al. Pyridinium oximes with ortho-positioned chlorine moiety exhibit improved physicochemical properties and efficient reactivation of human acetylcholinesterase inhibited by several nerve agents . J. Med. Chem 2018;61:10753–66.
   PubMed Web of Science ®Google Scholar
• Mercey G, Verdelet T, Renou J, et al. Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents. Acc Chem Res 2012;45:756–66.
   PubMed Web of Science ®Google Scholar
• Chambers JE, Dail MB, Meek EC. Oxime-mediated reactivation of organophosphate-inhibited acetylcholinesterase with emphasis on centrally-active oximes. Neuropharmacology 2020;175:108201.
   PubMed Web of Science ®Google Scholar
• Kuča K, Bielavský J, Cabal J, et al. Synthesis of a potential reactivator of acetylcholinesterase—1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium)propane dibromide. Tetrahedron Lett 2003;44:3123–5.
   Web of Science ®Google Scholar
• Kuca K, Bielavsky J, Cabal J, et al. Synthesis of a new reactivator (I) of tabun-inhibited acetylcholinesterase. Bioorg. Med. Chem. Lett 2003;20:3545–7.
   Google Scholar
• Musilek K, Jun D, Cabal J, et. al. Design of a potent reactivator of tabun-inhibited acetylcholinesterase-synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203). J Med Chem 2007;50:5514–8.
   PubMed Web of Science ®Google Scholar
• de Castro AA, Assis LC, Soares FV, et al. Trends in the recent patent literature on cholinesterase reactivators (2016–2019). Biomolecules 2020;10:436.
   PubMed Web of Science ®Google Scholar
• Čalić M, Vrdoljak AL, Radić B, et al. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity. Toxicology 2006;219:85–96.
   PubMed Web of Science ®Google Scholar
• Kuca K, Musilek K, Jun D, et al. A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase. BMC Pharmacology and Toxicology 2018;19:8.
   PubMed Web of Science ®Google Scholar
• Kassa J, Karasová Ž, Krejčiová JM. Therapeutic efficacy of a novel bispyridinium oxime K203 and commonly used oximes (HI-6, obidoxime, trimedoxime, methoxime) in soman-poisoned male rats and mice. J. Appl. Biomed 2013;11:7–13.
   Web of Science ®Google Scholar
• Petroianu GA, Hasan MY, Nurulain SM, et al. New K-oximes (K-27 and K-48) in comparison with obidoxime (LuH-6), HI-6, trimedoxime (TMB-4), and pralidoxime (2-PAM): survival in rats exposed IP to the organophosphate paraoxon. Toxicol. Mech. Methods 2007;17:401–8.
   PubMed Web of Science ®Google Scholar
• Musilek K, Holas O, Misik J, et al. Monooxime-monocarbamoyl bispyridinium xylene-linked reactivators of acetylcholinesterase-synthesis, in vitro and toxicity evaluation, and docking studies. ChemMedChem 2010;5:247–54.
   PubMed Web of Science ®Google Scholar
• Musilek K, Komloova M, Holas O, et al. Mono-oxime bisquaternary acetylcholinesterase reactivators with prop-1,3-diyl linkage—preparation, in vitro screening and molecular docking. Bioorg. Med. Chem 2011;19:754–62.
   PubMed Web of Science ®Google Scholar
• Malinak D, Nepovimova E, Jun D, et al. Novel group of AChE reactivators—synthesis, in vitro reactivation and molecular docking study. Molecules 2018;23:2291.
   PubMed Web of Science ®Google Scholar
• Musilek K, Kuca K, Jun D, et al. Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. Bioorg. Med. Chem. Lett 2006;16:622–7.
   PubMed Web of Science ®Google Scholar
• Pachon-Angona I, Refouvelet B, Andrys R, et al. Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer's disease therapy. J Enzyme Inhib Med Chem 2019;34:479–89.
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres V, et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.
   PubMed Web of Science ®Google Scholar
• Worek F, von der Wellen J, Musilek K, et al. Reactivation kinetics of a homologous series of bispyridinium bis-oximes with nerve agent-inhibited human acetylcholinesterase. Arch Toxicol 2012;86:1379–86.
   PubMed Web of Science ®Google Scholar
• Handl J, Malinak D, Capek J, et al. Effects of charged oxime reactivators on the HK-2 cell line in renal toxicity screening. Chem Res Toxicol 2021;34:699–703.
   PubMed Web of Science ®Google Scholar
• Dohoda D, Tsinman K, Tsinman O, et al. Spectrophotometric pKa determination of ionizable pharmaceuticals: resolution of molecules with weak pH-dependent spectral shift. Journal of Pharmaceutical and Biomedical Analysis 2015;114:88–96.
   PubMed Web of Science ®Google Scholar
• Meek EC, Chambers HW, Coban A, et al. Synthesis and in vitro and in vivo inhibition potencies of highly relevant nerve agent surrogates. Toxicol Sci 2012;126:525–33.
   PubMed Web of Science ®Google Scholar
• Čadež T, Kolić D, Šinko G, et al. Assesments of four organophosphorus pesticides as inhibitors of human acetylcholinesterase and butyrylcholinesterase. Sci. Rep 2021;11:21486.
   PubMed Web of Science ®Google Scholar
• Malinak D, Dolezal R, Hepnarova V, et al. Synthesis, in vitro screening and molecular docking of isoquinolinium-5-carbaldoximes as acetylcholinesterase and butyrylcholinesterase reactivators . J Enzyme Inhib Med Chem 2020;35:478–88.
   PubMed Web of Science ®Google Scholar
• Winter M, Wille T, Musilek K, et al. Investigation of the reactivation kinetics of a large series of bispyridinium oximes with organophosphate-inhibited human acetylcholinesterase. Toxicol Lett 2016;244:136–42.
   PubMed Web of Science ®Google Scholar